| Not Yet Recruiting | eHealth Mindfulness-based Music Therapy Intervention for Patients Undergoing Stem Cell Transplantation NCT07469592 | University of Miami | N/A |
| Not Yet Recruiting | Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event NCT07499128 | National Cancer Institute (NCI) | N/A |
| Not Yet Recruiting | Virtual Buddy Movement Therapy for Psychomotor and Social Development in Pediatric Oncology Patients in Remiss NCT07522905 | Comenius University | N/A |
| Recruiting | Phase I Clinical Trial of CART Cell Therapy for Refractory/Relapsed Acute Lymphoblastic Leukemia in Children, NCT06709469 | Instituto de Investigación Hospital Universitario La Paz | Phase 1 |
| Enrolling By Invitation | Effectiveness of Probiotics for the Prevention of Gastrointestinal Toxicity in Children With Leukemia NCT06560879 | National Institute of Pediatrics, Mexico | Phase 2 |
| Recruiting | CART123 T Cells in Relapsed or Refractory CD123+ Hematologic Malignancies: A Dose Escalation Phase I Trial NCT06765876 | Institute of Hematology and Blood Transfusion, Czech Republic | EARLY_Phase 1 |
| Recruiting | A Study to Investigate Safety of INT2104 Infusions in Participants Aged 18 Years of Age and Older Who Have B-c NCT06539338 | Kite, A Gilead Company | Phase 1 |
| Recruiting | Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL NCT06387121 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Active Not Recruiting | Electronic Health Mindfulness-based Music Therapy Intervention for Patients Undergoing Allogeneic Stem Cell Tr NCT05968963 | University of Miami | N/A |
| Recruiting | MRD-associated Non-intensive But Non-interruptive Treatment of Ph-negative Acute Lymphoblastic Leukemia Adult NCT06237192 | National Research Center for Hematology, Russia | N/A |
| Recruiting | Glucose Intolerance and Diabetes Related to Treatment With Steroids and PEG- Asparaginase in Children and Adol NCT05873322 | Aarhus University Hospital | — |
| Recruiting | Pediatric-inspired Regimen Combined With Venetoclax for Adolescent and Adult Patients With de Novo Philadelphi NCT05660473 | Institute of Hematology & Blood Diseases Hospital, China | Phase 2 |
| Unknown | A Study of Dasatinib Plus Reduced Intensive Consolidation Chemotherapy in Ph+ Adult ALL NCT05026229 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Unknown | A Study of TKI Maintenance Therapy Following Allo-HSCT in Newly Diagnosed Ph+ Adult ALL NCT05024357 | First Affiliated Hospital Xi'an Jiaotong University | N/A |
| Withdrawn | The Value of Follow-Up After Childhood Acute Lymphoblastic Leukaemia in Denmark - Family Perspectives NCT03985215 | University of Aarhus | — |
| Withdrawn | Intravenous Ixazomib in Pediatric Participants With Relapsed or Refractory Acute Lymphoblastic Leukemia (ALL) NCT03888534 | Millennium Pharmaceuticals, Inc. | Phase 1 |
| Completed | InO - A Retrospective Study of UK Patients With Leukaemia NCT04456959 | Pfizer | — |
| Completed | Health Care Utilisation Among Survivors of Childhood Acute Lymphoblastic Leukaemia NCT03985826 | University of Aarhus | — |
| Terminated | A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B- NCT03743246 | Celgene | Phase 1 / Phase 2 |
| Completed | Childhood Acute Lymphoblastic Leukaemia: Follow-Up NCT03545659 | University of Aarhus | — |
| Completed | A Study to Evaluate the Efficacy and Safety of Daratumumab in Pediatric and Young Adult Participants Greater T NCT03384654 | Janssen Research & Development, LLC | Phase 2 |
| Unknown | De-escalated Treatment Approach for Adult Ph-negative Acute Lymphoblastic Leukemia (ALL) NCT03462095 | National Research Center for Hematology, Russia | N/A |
| Withdrawn | A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphobla NCT02973191 | Celgene | Phase 1 / Phase 2 |
| Unknown | Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias NCT02759822 | Leonardo Javier Arcuri | — |
| Terminated | A Dose Escalation Study of Duvortuxizumab in Participants With Relapsed or Refractory B-cell Malignancies NCT02454270 | Janssen Research & Development, LLC | Phase 1 |
| Recruiting | Phase I Trial of TURALIO(R) (Pexidartinib, PLX3397) in Children and Young Adults With Refractory Leukemias and NCT02390752 | National Cancer Institute (NCI) | Phase 1 |
| Terminated | Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia (2015) NCT02428517 | Asan Medical Center | — |
| Unknown | A 5 Day Course of Fludarabine and Cytarabine Followed by Full Intensity Allogeneic Stem Cell Transplantation ( NCT02328950 | Fujian Medical University | — |
| Terminated | Azacitidine in Patients Undergoing Matched Unrelated Stem Cell Transplantation NCT01747499 | Washington University School of Medicine | Phase 1 / Phase 2 |
| Unknown | Rituximab+mVPDL for CD20(+) Adult Acute Lymphoblastic Leukemia NCT01429610 | Asan Medical Center | Phase 2 |
| Completed | Disrupting the Bone Marrow Microenvironment With G-CSF in Acute Lymphoblastic Leukemia NCT01331590 | Washington University School of Medicine | EARLY_Phase 1 |
| Completed | Nutrition and Body Composition in Acute Lymphoblastic Leukemia NCT01317940 | Children's Hospital Los Angeles | Phase 2 |
| Completed | Prevention of Left Ventricular Dysfunction During Chemotherapy NCT01110824 | Hospital Clinic of Barcelona | Phase 3 |
| Completed | NK DLI in Patients After Human Leukocyte Antigen (HLA)-Haploidentical Hematopoietic Stem Cell Transplantation NCT01386619 | University Hospital, Basel, Switzerland | Phase 1 / Phase 2 |